Showing 2,391 - 2,400 of 2,410
Persistent link: https://www.econbiz.de/10013481071
Persistent link: https://www.econbiz.de/10013481074
Persistent link: https://www.econbiz.de/10013481090
Persistent link: https://www.econbiz.de/10013409839
Given recent controversies about the existence of a gender wellbeing gap we revisit the issue estimating gender differences across 55 subjective well-being metrics - 37 positive affect and 18 negative affect - contained in 8 cross-country surveys from 167 countries across the world, two US...
Persistent link: https://www.econbiz.de/10014287313
We find that financial conditions in the core have significant spillover effects on cross-border mergers and acquisitions (M&As). On average, a 1 percentage point easing of the IMF US Financial Conditions Index is associated with approximately a 10% higher volume of cross-border M&As. The...
Persistent link: https://www.econbiz.de/10014287336
A growing fraction of companies globally have made commitments to reduce their carbon emissions by a certain date. While the companies that make commitments subsequently reduce their emissions, the effect on overall emissions of companies (including those that do not commit) has been small; the...
Persistent link: https://www.econbiz.de/10014287345
This paper explores the relationship between different funding structures--including the source, instrument, currency, and counterparty location of funding--and the extent of financial stress experienced in different countries and sectors during the sharp risk-off shock in early 2020 when...
Persistent link: https://www.econbiz.de/10014287355
This paper uses the onset of COVID-19 to examine how countries construct their policy packages in response to a severe negative shock. We use several new datasets to track the use of a large variety of policy tools: announced fiscal stimulus (both above- and below-the-line), monetary policy...
Persistent link: https://www.econbiz.de/10014287372
In his Labor Day address, President Biden stated that the U.S. "has the highest drug prices in the world, and there is no reason for it." For new branded drugs, the first part of that statement is supported by a recent RAND Report (Mulcahy et. al. 2021) which found U.S. average prices are 2.3...
Persistent link: https://www.econbiz.de/10014287373